InoCardia ^Company

Inocardia is a Coventry University spinout focused on the provision of Contract Research Services via the development of assays targeted at the biotech and pharmaceutical sectors. Inocardia has developed the вАШwork-loopвАЩ model as a pre-clinical myocardial assay assessing cardiac contractility in normal, diseased and ageing myocardium in order to determine the cardiovascular safety of lead pharmaceutical compounds. The Coventry University work-loop assay is the only relevant in-vitro human model of cardio-toxicity available worldwide. Both the pharmaceutical industry and regulators recognise that contractility assessment is currently fraught with problems.